SEP 10, 2026 · JOURNAL ARTICLE
Programmable Organic A2S-TT NPs for NIR-II/Photoacoustic Imaging-Enabled Precision Therapy
Pharmaceutics
Preclinical proof-of-concept study in cell and mouse models of a novel nanoparticle platform; no human data, efficacy metrics lack quantitative comparison to standard therapy, and no phase 1 translation reported.
Study details
DesignUncontrolled preclinical study (in vitro an…
InterventionA2S-TT nanoparticles administered with 808…